Efficacy and safety of tenofovir disoproxil fumarete (TDF) in nucleos(t)ide analogue-naive patients with hepatitis B virus
Not Applicable
Recruiting
- Conditions
- Patients with chronic hepatitis B virus infection
- Registration Number
- JPRN-UMIN000017728
- Lead Sponsor
- Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) pregnant woman 2) co-infection with other hepatitis virus (HCV/HDV/HIV) 3) contraindication to tenofovir disoploxil fumarate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method probability of HBV DNA negativity dicrease rate of HB surface antigen level dicrease rate of HB core-related antigen probability of HBe antigen seroconversion probability of ALT normalization cumulative incidence rate of hepatocellular carcinoma
- Secondary Outcome Measures
Name Time Method